Document is current

Any future updates will be listed below

Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery

Crossref DOI link: https://doi.org/10.1186/s13045-016-0301-2

Published Online: 2016-08-17

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark